Liver Cirrhosis Pipeline Highlights Report 2017 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Liver Cirrhosis Pipeline Highlights - 2017" drug pipelines to their offering.

This report, Liver Cirrhosis Pipeline Highlights - 2017, provides most up-to-date information on key pipeline products in the global Liver Cirrhosis market. It covers emerging therapies for Liver Cirrhosis in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides Liver Cirrhosis pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Liver Cirrhosis pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:

The report provides Liver Cirrhosis pipeline products by the company.

Short-term Launch Highlights:

Find out which Liver Cirrhosis pipeline products will be launched in the US and Ex-US till 2020.

Key Topics Covered:

1. Liver Cirrhosis Pipeline by Stages

2. Liver Cirrhosis Pipeline by Drug Class

3. Liver Cirrhosis Pipeline by Company

4. Liver Cirrhosis Phase 3 Clinical Trial Insights

5. Liver Cirrhosis Phase 2 Clinical Trial Insights

6. Liver Cirrhosis Phase 1 Clinical Trial Insights

7. Liver Cirrhosis Preclinical Research Insights

8. Liver Cirrhosis Discovery Stage Insights

9. Appendix

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/bvwhlq/liver_cirrhosis

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Liver and Kidney Disorders Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Liver and Kidney Disorders Drugs